These genes likely involved in resensitization to olaparib were associated with the following biological processes: beta-catenin-independent WNT signaling (TNRC6A and CLTC), G2/M DNA damage checkpoint (YWHAQ), loss of function of TGFβR1 in cancer (SMAD2), and transcriptional regulation by small RNAs (TNRC6A and POLR2A) (Table S5). This evidence concerns the gene TGFBR1 and cancer.